148 related articles for article (PubMed ID: 28066412)
1. Human C1q Induces Apoptosis in an Ovarian Cancer Cell Line
Kaur A; Sultan SH; Murugaiah V; Pathan AA; Alhamlan FS; Karteris E; Kishore U
Front Immunol; 2016; 7():599. PubMed ID: 28066412
[TBL] [Abstract][Full Text] [Related]
2. Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth.
Agostinis C; Vidergar R; Belmonte B; Mangogna A; Amadio L; Geri P; Borelli V; Zanconati F; Tedesco F; Confalonieri M; Tripodo C; Kishore U; Bulla R
Front Immunol; 2017; 8():1559. PubMed ID: 29209316
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in the understanding of the structure-function relationships of the globular head regions of C1q.
Kishore U; Kojouharova MS; Reid KB
Immunobiology; 2002 Sep; 205(4-5):355-64. PubMed ID: 12395999
[TBL] [Abstract][Full Text] [Related]
4. Complement Protein C1q Interacts with DC-SIGN
Pednekar L; Pandit H; Paudyal B; Kaur A; Al-Mozaini MA; Kouser L; Ghebrehiwet B; Mitchell DA; Madan T; Kishore U
Front Immunol; 2016; 7():600. PubMed ID: 28066413
[TBL] [Abstract][Full Text] [Related]
5. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.
Nauta AJ; Trouw LA; Daha MR; Tijsma O; Nieuwland R; Schwaeble WJ; Gingras AR; Mantovani A; Hack EC; Roos A
Eur J Immunol; 2002 Jun; 32(6):1726-36. PubMed ID: 12115656
[TBL] [Abstract][Full Text] [Related]
6. The non-classical functions of the classical complement pathway recognition subcomponent C1q.
Nayak A; Ferluga J; Tsolaki AG; Kishore U
Immunol Lett; 2010 Jul; 131(2):139-50. PubMed ID: 20381531
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR.
Pednekar L; Pathan AA; Paudyal B; Tsolaki AG; Kaur A; Abozaid SM; Kouser L; Khan HA; Peerschke EI; Shamji MH; Stenbeck G; Ghebrehiwet B; Kishore U
Front Immunol; 2016; 7():567. PubMed ID: 28018340
[TBL] [Abstract][Full Text] [Related]
9. Modular organization of proteins containing C1q-like globular domain.
Kishore U; Reid KB
Immunopharmacology; 1999 May; 42(1-3):15-21. PubMed ID: 10408361
[TBL] [Abstract][Full Text] [Related]
10. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
[TBL] [Abstract][Full Text] [Related]
12. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.
Bulla R; Tripodo C; Rami D; Ling GS; Agostinis C; Guarnotta C; Zorzet S; Durigutto P; Botto M; Tedesco F
Nat Commun; 2016 Feb; 7():10346. PubMed ID: 26831747
[TBL] [Abstract][Full Text] [Related]
13. Emerging and Novel Functions of Complement Protein C1q.
Kouser L; Madhukaran SP; Shastri A; Saraon A; Ferluga J; Al-Mozaini M; Kishore U
Front Immunol; 2015; 6():317. PubMed ID: 26175731
[TBL] [Abstract][Full Text] [Related]
14. C1q and tumor necrosis factor superfamily: modularity and versatility.
Kishore U; Gaboriaud C; Waters P; Shrive AK; Greenhough TJ; Reid KB; Sim RB; Arlaud GJ
Trends Immunol; 2004 Oct; 25(10):551-61. PubMed ID: 15364058
[TBL] [Abstract][Full Text] [Related]
15. Factor H as a regulator of the classical pathway activation.
Kishore U; Sim RB
Immunobiology; 2012 Feb; 217(2):162-8. PubMed ID: 21852018
[TBL] [Abstract][Full Text] [Related]
16. Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas.
Mangogna A; Agostinis C; Bonazza D; Belmonte B; Zacchi P; Zito G; Romano A; Zanconati F; Ricci G; Kishore U; Bulla R
Front Immunol; 2019; 10():865. PubMed ID: 31130944
[TBL] [Abstract][Full Text] [Related]
17. CHM-1 induces apoptosis via p38-mediated upregulation of DR5 expression in human ovarian cancer SKOV3 cells.
Lee JC; Chou LC; Huang CH; Chung JG; Huang LJ; Lee KH; Hung MC; Way TD; Kuo SC
Eur J Pharmacol; 2011 Nov; 670(1):96-104. PubMed ID: 21907193
[TBL] [Abstract][Full Text] [Related]
18. Complement and non-complement activating functions of C1q: a prototypical innate immune molecule.
Nayak A; Pednekar L; Reid KB; Kishore U
Innate Immun; 2012 Apr; 18(2):350-63. PubMed ID: 21450789
[TBL] [Abstract][Full Text] [Related]
19. C1q and its growing family.
Ghai R; Waters P; Roumenina LT; Gadjeva M; Kojouharova MS; Reid KB; Sim RB; Kishore U
Immunobiology; 2007; 212(4-5):253-66. PubMed ID: 17544811
[TBL] [Abstract][Full Text] [Related]
20. Structural and Functional Characterization of a Single-Chain Form of the Recognition Domain of Complement Protein C1q.
Moreau C; Bally I; Chouquet A; Bottazzi B; Ghebrehiwet B; Gaboriaud C; Thielens N
Front Immunol; 2016; 7():79. PubMed ID: 26973654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
